These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 29248575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L, Zhong X, Li Q, Zhang X, Wang Y, Yang K, Zhang LW.
    Toxicol Sci; 2017 Mar 01; 156(1):39-53. PubMed ID: 28013220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ.
    Res Commun Chem Pathol Pharmacol; 1991 May 01; 72(2):169-81. PubMed ID: 1876748
    [Abstract] [Full Text] [Related]

  • 12. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S, Matsumoto A, Mori I, Horinouchi A.
    Toxicol Mech Methods; 2009 Oct 01; 19(8):477-85. PubMed ID: 19793005
    [Abstract] [Full Text] [Related]

  • 13. Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen.
    Fusani L, Brown M, Chen H, Ahlberg E, Noeske T.
    Mol Pharm; 2017 Dec 04; 14(12):4346-4352. PubMed ID: 29077420
    [Abstract] [Full Text] [Related]

  • 14. Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals.
    Rodrigues RM, De Kock J, Branson S, Vinken M, Meganathan K, Chaudhari U, Sachinidis A, Govaere O, Roskams T, De Boe V, Vanhaecke T, Rogiers V.
    Stem Cells Dev; 2014 Jan 01; 23(1):44-55. PubMed ID: 23952781
    [Abstract] [Full Text] [Related]

  • 15. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
    Okamoto H, Hamaguchi R, Kuroda Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr 15; 1051():33-40. PubMed ID: 28285021
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased hepatic density and phospholipidosis due to amiodarone.
    Goldman IS, Winkler ML, Raper SE, Barker ME, Keung E, Goldberg HI, Boyer TD.
    AJR Am J Roentgenol; 1985 Mar 15; 144(3):541-6. PubMed ID: 3871563
    [Abstract] [Full Text] [Related]

  • 18. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM, Beard TL, Kacew S, Reasor MJ.
    Exp Mol Pathol; 1995 Feb 15; 62(1):12-21. PubMed ID: 7556587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.